[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![QuantumBP Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1012892543925850113.png) Quantum BioPharma [@QuantumBP](/creator/twitter/QuantumBP) on x 5745 followers
Created: 2025-07-08 12:03:47 UTC

Quantum BioPharma has submitted its patented MS drug candidate, Lucid-21-302 (Lucid-MS), to the UK’s Innovative Licensing and Access Pathway (ILAP) fast-track program.

Lucid-MS is a first-in-class treatment targeting demyelination in Multiple Sclerosis. 

The ILAP submission marks a key step in accelerating regulatory review, clinical development, and patient access in the UK.



#QNTM #LucidMS #Biotech #Neurodegeneration #MultipleSclerosis #DrugDevelopment #ClinicalTrials #UKLifeSciences #ILAP #MSawareness #NASDAQ $QNTM #Brainhealth #News #NHS

![](https://pbs.twimg.com/amplify_video_thumb/1942554946383032320/img/Hz3x0J22tZDi4G0A.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942555207658795215/c:line.svg)

**Related Topics**
[marks](/topic/marks)
[$qubt](/topic/$qubt)
[$issc](/topic/$issc)

[Post Link](https://x.com/QuantumBP/status/1942555207658795215)